Is Aligos Therapeutics, Inc. (ALGS) a Buy, Sell, or Hold?
NASDAQ : ALGS
Aligos Therapeutics, Inc.
$5.74 USD
-$0.01 (-0.17%)
- Volume
- 46.97K
- Average Volume
- 294.04K
- Market Capitalization
- $35.52M
- P/E Ratio
- -0.66
- Dividend Yield
- 0.00%
- Price Target
- $20.00
- Year High
- $13.69
- Year Low
- $4.80
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.56
ALGS vs. The Competition
| Properties | ALGS | BRNS | CVM | FGEN |
|---|---|---|---|---|
| Market Cap | $35.52M | $22.69M | $8.04M | $36.69M |
| Shares Outstanding | $6.19M | $40.85M | $6.87M | $4.05M |
| P/E Ratio | -0.66 | -0.43 | -0.34 | 0.22 |
| EPS | -8.68 | -1.28 | -2.79 | 40.43 |
| Day Low | 5.6 | 0.5555 | 1.09 | 9.02 |
| Day High | 5.85 | 0.6716 | 1.17 | 9.21 |
| Year Low | 4.8 | 0.512 | 0.89 | 4.85 |
| Year High | 13.689 | 2.91 | 13.48 | 21.95 |
| Average Price 50 | 5.7238 | 0.67378 | 1.2998 | 9.1405 |
| Average Price 200 | 7.6806 | 0.77123 | 4.60755 | 8.83568 |
| Volume | 46970 | 39137 | 455.26K | 29255 |
| Average Volume | - | - | - | - |